For research teamsHelp me find a study
Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
23847studies shown
Showing 19,453-19,464 of 23,847
Drug study icon
CompletedNCT00292370

Quetiapine Augmentation for Treatment-resistant PTSD

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Birmingham
PTSDDrugA study involving a medication or substance.From 18 Years to 75 Years
Countries
United States
Sponsor
VA Office of Research and Development
Condition
PTSD
View study
Drug study icon
CompletedNCT00254735

Quetiapine Augmentation in Severe OCD

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Freiburg im Breisgau
OCDDrugFrom 18 Years to 65 Years
Countries
Germany
Sponsor
AstraZeneca
Condition
OCD
View study
Drug study icon
CompletedNCT00523601

Quetiapine Efficacy in Depression in bipolarity Study

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Kyungki-do
Bipolarity, DepressionOtherFrom 18 Years to 65 Years
Countries
South Korea
Sponsor
AstraZeneca
Condition
Bipolarity, Depression
View study
Drug study icon
CompletedNCT00671853

Quetiapine Extended Release (XR) in Bipolar people with Comorbid Generalized Anxiety Disorder (GAD)

This study exists to explore whether a therapy or guided support program could improve care and understanding. Researchers are trying to understand whether a therapy or guided support program can work better when mental health difficulties overlap with substance use.

In Cleveland
Bipolarity, Anxiety, ...DrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
University Hospitals Cleveland Medical Center
Condition
Bipolarity, Anxiety, ...
View study
Drug study icon
CompletedNCT00640562

Quetiapine Extended Release Depression Symptoms

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Fermo
Depression, SchizophreniaDrugFrom 18 Years to 65 Years
Countries
Italy
Sponsor
AstraZeneca
Condition
Depression, Schizophrenia
View study
Drug study icon
CompletedNCT00457197

Quetiapine for Bipolarity and Alcohol Dependence

This study exists to explore whether a medication treatment could improve care and understanding. Researchers are trying to understand whether a medication treatment can work better when mental health difficulties overlap with substance use.

In Dallas
BipolarityDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
University of Texas Southwestern Medical Center
Condition
Bipolarity
View study
Drug study icon
CompletedNCT00232336

Quetiapine for Cocaine Use and Cravings

This summary needs review. Please check the official study record and contact the research team for details.

In Tacoma
AddictionDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Seattle Institute for Biomedical and Clinical Research
Condition
Addiction
View study
Drug study icon
CompletedNCT00631748

Quetiapine for the Reduction of Cocaine Use

This summary needs review. Please check the official study record and contact the research team for details.

In Tacoma
AddictionDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Seattle Institute for Biomedical and Clinical Research
Condition
Addiction
View study
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.